NRXP: NRx Defense Systems, an NRx Company (Nasdaq:NRXP) Awarded $11 Million Dollar DARPA Prime Contract to Evaluate Robotic Magnetic Stimulation in conjunction with NRX-101 for Treatment of Resistant Depression
FDA reclassifies NRx Pharmaceuticals ketamine amendment from major to minor
NRx Pharmaceuticals explores ketamine opportunity in psychiatry
GeNeuro awarded European patent for GNK-301 ALS drug candidate